“Prader–Willi Syndrome Market” report has been added to DelveInsight
The Prader–Willi Syndrome market report provides an edge while developing business strategies, by understanding trends shaping and driving the global Prader–Willi Syndrome market. A detailed review of the historical and forecasted Prader–Willi Syndrome market is included in the report, covering drug outreach in the 7MM countries.
Prader–Willi Syndrome Disease: Overview and In-depth Understanding
Prader-will syndrome is a complex genetic condition that affects many parts of the body. This condition is characterized by weak muscle tone (hypotonia), feeding difficulties, poor growth and delayed development in infancy. Begining in childhood, affected individuals develop insatiable appetite, which leads to chronic overeating (hyperphagia) and obesity.
Request for free sample copy @ https://www.delveinsight.com/sample-request/prader-willi-syndrome-market
Prader–Willi Syndrome Market: By Regions
- The United States
- EU5 (Germany, France, Italy, Spain, and the United Kingdom)
- Japan
Prader–Willi Syndrome Key Players
- Levo Therapeutics
- Harmony Biosciences
- Soleno Therapeutics
- Lipidio Pharmaceuticals
- And many others
Prader–Willi Syndrome Drugs
- Diazoxide Choline Controlled-Release (DCCR)
- LV-101
- And many others
Prader–Willi Syndrome Market Disease
The disease occurs due to the loss of function of several genes in a particular region of chromosome number 15. Among these are genes that provide instructions for making molecules called small nucleolar RNAs (snoRNAs).
Prader–Willi Syndrome Market Report
Prader-Will syndrome (PWS) is the first syndromic form of the neurodevelopmental disorder that was confirmed to be caused due to imprinting errors leading to a multisystem genetic disorder characterized during infancy by lethargy, diminished muscle tone (hypotonia), feeding difficulties, poor weight gain and growth hormone deficiency. Although considered a “rare” disorder, PWS is one of the most common conditions seen in genetic clinics and is the most common genetic cause of obesity that has been identified to date.
Prader–Willi Syndrome Treatment Market
The treatment of PWS is currently based on treating the symptoms of the disorder as they arise. Growth hormone deficiency is present in almost all children and many adults with PWS. In multiple studies, human growth hormone (HGH) has been found to be beneficial for those with Prader-Willi syndrome. In June of 2000, HGH was officially approved by the Federal Drug Administration (FDA) in the United States for use in patients with Prader-Willi syndrome. HGH is effective not only in increasing height, but also in decreasing body fat, increasing muscle mass, improving weight distribution, increasing stamina, and increasing bone mineral density. Some of the major approved GH therapies include Pfizer’s Genotropin (somatropin) along with other major brands such as Norditropin (Novo Nordisk) and a few others in the US.
Prader–Willi Syndrome Market Outlook
Currently, there is no cure for PWS. The lives of individuals with PWS can be improved with early diagnosis and careful management of symptoms, but more effective therapies are needed.
Prader–Willi Syndrome Market Research
The global PWS market is marked by symptomatic therapies used for treating the co-morbidities such as diabetes, obesity, cardiovascular disorders, etc. associated with PWS, and the rising awareness and improvement in the diagnosis of the disease shall serve as vital market drivers for PWS.
Request for free sample copy @ https://www.delveinsight.com/sample-request/prader-willi-syndrome-market
List of Table of content
- Key Insights
- Executive Summary of Prader-Willi Syndrome
- Competitive Intelligence Analysis for Prader-Willi Syndrome
- Prader-Willi Syndrome Market Overview at a Glance
- Prader-Willi Syndrome Disease Background and Overview
- Patient Journey
- Prader-Willi Syndrome Epidemiology and Patient Population
- Treatment Algorithm, Current Treatment, and Medical Practices
- Unmet Needs
- Key Endpoints of Prader-Willi Syndrome Treatment
- Marketed Products
- Emerging Therapies
- Prader-Willi Syndrome: Seven Major Market Analysis
- Attribute analysis
- 7MM: Market Outlook
- Access and Reimbursement Overview of Prader-Willi Syndrome
- KOL Views
- Market Drivers
- Market Barriers
- Appendix
- DelveInsight Capabilities
- Disclaimer
- About DelveInsight
Prader-Willi Syndrome Market Barriers
- Treatment Cost
- Need for novel therapeutics
- High failure rate of trials
Prader-Willi Syndrome Market Drivers
- Increase in research activities
- Increasing disease prevalence
- Surge in a number of clinical studies
Prader-Willi Syndrome Market Research Methodology
The objective of updating DelveInsight coverage is to ensure that it represents the most up-to-date vision of the industry possible. The DelveInsight is a fully integrated solution for comprehensive intelligence on various pharmaceutical products, both in the market and in the pipeline, across the globe.
About Us
DelveInsight is a Business Consultant company and serves as a Knowledge partner across the value chain of the Pharmaceutical Industry. With the use of proprietary databases and analytical models, DelveInsight provides cutting-edge market and pipeline analysis and API intelligence across all therapy areas to the Pharma and biotech sector, helping clients to quantify market events and evaluate their impact on the valuation of products, portfolios, and companies.
Contact us
Shruti Thakur
info@delveinsight.com
+91-9650213330
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Phone: +919650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/